Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harli Weber

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Neurology|February 20, 2025
Implementing a Neurology Mentorship Program to Ease Residency Application Process (P1-7.008)Audrey Huang, Harli Weber, Chaitanya Medicherla, et al.
Annals of the New York Academy of Sciences|September 28, 2021
Outcome and prognostication after cardiac arrestTheresa Henson, Cameron Rawanduzy, Marco Salazar, et al.
Journal of Critical Care|March 30, 2025
ICU-acquired weakness: Critical illness myopathy and polyneuropathyAudrey Huang, Marco Salazar, Harli Weber, et al.
American Journal of Physical Medicine & Rehabilitation|March 25, 2025
Assistive Technology in ALS: A Scoping Review of Devices for Limb, Trunk, and Neck WeaknessKatherine M Burke, Vishni Arulanandam, Erica Scirocco, et al.
Annals of Clinical and Translational Neurology|May 30, 2019
Design and results of a smartphone-based digital phenotyping study to quantify ALS progressionJames D Berry, Sabrina Paganoni, Kenzie Carlson, et al.
Muscle & Nerve|March 17, 2023
Expanded access protocol (EAP) program for access to investigational products for amyotrophic lateral sclerosis (ALS)Megan Yerton, Allison Winter, Dario Gelevski, et al.
Muscle & Nerve|June 29, 2022
An expanded access protocol of RT001 in amyotrophic lateral sclerosis-Initial experience with a lipid peroxidation inhibitorMegan Yerton, Allison Winter, Anthony Kostov, et al.
Muscle & Nerve|December 19, 2022
Safety and activity of anti-CD14 antibody IC14 (atibuclimab) in ALS: Experience with expanded access protocolDario Gelevski, Grace Addy, Margot Rohrer, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Neurology|February 20, 2025
Implementing a Neurology Mentorship Program to Ease Residency Application Process (P1-7.008)Audrey Huang, Harli Weber, Chaitanya Medicherla, et al.
Annals of the New York Academy of Sciences|September 28, 2021
Outcome and prognostication after cardiac arrestTheresa Henson, Cameron Rawanduzy, Marco Salazar, et al.
Journal of Critical Care|March 30, 2025
ICU-acquired weakness: Critical illness myopathy and polyneuropathyAudrey Huang, Marco Salazar, Harli Weber, et al.
American Journal of Physical Medicine & Rehabilitation|March 25, 2025
Assistive Technology in ALS: A Scoping Review of Devices for Limb, Trunk, and Neck WeaknessKatherine M Burke, Vishni Arulanandam, Erica Scirocco, et al.
Annals of Clinical and Translational Neurology|May 30, 2019
Design and results of a smartphone-based digital phenotyping study to quantify ALS progressionJames D Berry, Sabrina Paganoni, Kenzie Carlson, et al.
Muscle & Nerve|March 17, 2023
Expanded access protocol (EAP) program for access to investigational products for amyotrophic lateral sclerosis (ALS)Megan Yerton, Allison Winter, Dario Gelevski, et al.
Muscle & Nerve|June 29, 2022
An expanded access protocol of RT001 in amyotrophic lateral sclerosis-Initial experience with a lipid peroxidation inhibitorMegan Yerton, Allison Winter, Anthony Kostov, et al.
Muscle & Nerve|December 19, 2022
Safety and activity of anti-CD14 antibody IC14 (atibuclimab) in ALS: Experience with expanded access protocolDario Gelevski, Grace Addy, Margot Rohrer, et al.
Pageof 1